Tens of thousands of Black men across the UK are set to be offered prostate cancer screening as part of a major national research programme aimed at improving the early detection of the disease. The government has announced an £18 million expansion of the Transform trial, which will specifically invite Black men aged between 45 and 74 to participate in research examining more effective methods of prostate cancer screening.

Health charities and campaign groups have welcomed the move, describing it as a significant breakthrough in efforts to address disparities in cancer outcomes among higher-risk groups.

The announcement follows the UK National Screening Committee's recent recommendation against introducing routine prostate cancer screening for the wider male population. While men can request a prostate-specific antigen (PSA) blood test through their GP, experts continue to caution against mass screening due to concerns over accuracy and potential overtreatment.

According to the committee, the disadvantages of widespread PSA testing currently outweigh the benefits for most men. Although screening can identify some cancers earlier and potentially save lives, it can also result in unnecessary treatment for slow-growing tumours that may never become life-threatening.

Such treatments can carry serious side effects, including urinary incontinence and erectile dysfunction, making the decision to screen healthy men particularly complex.

However, the committee recognised that certain groups face a significantly higher risk of developing the disease. Prostate cancer remains the most commonly diagnosed cancer among men in the UK, with around 64,000 new cases and approximately 12,000 deaths recorded annually.

While one in eight men will develop prostate cancer during their lifetime, the risk rises dramatically among Black men, affecting around one in four.

The expanded Transform trial will investigate whether combining PSA testing with additional screening tools, including genetic assessments and rapid MRI scanning, can improve detection rates while reducing unnecessary diagnoses and treatments.

Officials say all eligible Black men aged 45 to 74 who have not recently undergone a PSA test will be invited to take part in the study.

Researchers hope the findings will help shape a more accurate and effective national screening programme in the future, particularly for those most vulnerable to the disease.

Health Secretary James Murray said the investment marked an important step in the fight against prostate cancer.

"This is a major step forward in how we tackle prostate cancer, focusing on those at greatest risk, improving the treatment options available, and supporting the research needed to fill crucial evidence gaps and save lives," he said.

The trial began recruiting participants earlier this year and is expected to provide valuable data on how best to identify prostate cancer at an earlier stage.

Prostate Cancer UK welcomed the government's decision, saying it was "delighted" by the expansion of the programme. The charity said the initiative would help ensure more Black men receive reliable information about their risk and the benefits of taking part in screening research.

Campaigners hope the study will pave the way for a more targeted approach to prostate cancer detection, helping to improve survival rates and reduce inequalities in healthcare outcomes for future generations.